Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.15 trillion and total revenue of $109.89 billion.
Market Cap
1.15T
Revenue
109.89B
Profits
-41.56B
PE Ratio
n/a
Profit Margin
-37.82%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.63B | -1.60% | 2,993,018 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.05B | 0.33% | 2,609,191 | 14.92B |
| 3 | ARGX | argenx SE | 54.44B | -1.63% | 351,969 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.13B | -1.64% | 2,204,539 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 34.65B | 3.31% | 4,702,384 | - |
| 6 | RPRX | Royalty Pharma plc | 30.50B | -1.38% | 8,608,463 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 30.03B | 2.84% | 367,881 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 25.38B | 3.50% | 24,078,821 | 2.23B |
| 9 | BNTX | BioNTech SE | 22.98B | -1.44% | 938,366 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 22.61B | 0.74% | 8,263,042 | 8.26M |
| 11 | INSM | Insmed Incorporated | 20.76B | -2.69% | 23,379,075 | 819.56M |
| 12 | INCY | Incyte Corporation | 19.62B | -0.78% | 4,058,623 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.34B | -0.47% | 1,809,919 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.34B | -0.14% | 891,669 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.10B | -1.00% | 1,906,921 | 4.44B |
| 16 | EXEL | Exelixis, Inc. | 13.05B | -1.01% | 6,544,908 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.98B | -1.66% | 3,815,337 | 579.96M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.89B | -0.66% | 770,861 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.25B | -0.26% | 2,984,375 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.66B | 1.18% | 486,932 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.52B | 0.96% | 3,863,359 | 622.01M |
| 22 | CYTK | Cytokinetics, Incorporated | 10.70B | 0.86% | 3,547,407 | 105.82M |
| 23 | SMMT | Summit Therapeutics Inc. | 10.67B | -2.27% | 8,723,161 | - |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.57B | -0.60% | 3,481,455 | 3.24B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.26B | 1.87% | 811,411 | 417.30M |
| 26 | NUVL | Nuvalent, Inc. | 9.75B | 0.06% | 4,603,597 | - |
| 27 | TECH | Bio-Techne Corporation | 9.07B | 5.35% | 3,773,089 | 1.21B |
| 28 | CORT | Corcept Therapeutics Incorporated | 8.58B | -2.25% | 1,873,665 | 769.10M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.13B | -0.03% | 3,653,954 | 1.51B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.88B | -1.00% | 1,701,700 | 5.67M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.87B | 4.56% | 680,689 | 7.46M |
| 32 | IBRX | ImmunityBio, Inc. | 7.71B | 5.29% | 14,372,395 | 140.98M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 7.67B | 0.97% | 2,420,415 | - |
| 34 | TGTX | TG Therapeutics, Inc. | 7.54B | 3.34% | 7,172,559 | 700.35M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 7.44B | 0.59% | 1,262,245 | 51.48M |
| 36 | PCVX | Vaxcyte, Inc. | 7.43B | 1.52% | 2,837,023 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 7.26B | 1.27% | 1,524,433 | 74.06M |
| 38 | IMVT | Immunovant, Inc. | 7.26B | 1.82% | 3,888,369 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.77B | 2.21% | 1,970,053 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.63B | 1.00% | 1,558,967 | 217.17M |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.55B | 0.57% | 2,870,578 | 827.11M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 4.99% | 1,576,672 | 569.61M |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.19B | 0.38% | 5,556,307 | 15.00M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.90B | 2.58% | 4,894,173 | - |
| 45 | BLTE | Belite Bio, Inc | 5.75B | -1.50% | 255,086 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.67B | 0.81% | 3,059,253 | - |
| 47 | LGND | Ligand Pharmaceuticals Incorporated | 5.51B | 4.46% | 609,561 | 274.48M |
| 48 | CGON | CG Oncology, Inc. | 5.39B | 1.08% | 2,257,672 | 5.07M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.22B | 3.42% | 2,398,379 | 907.29M |
| 50 | CRSP | CRISPR Therapeutics AG | 5.22B | 1.88% | 1,940,878 | 4.10M |
| 51 | LEGN | Legend Biotech Corporation | 5.19B | -16.68% | 13,608,396 | 1.14B |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.13B | 1.87% | 6,587,036 | 536.20M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.11B | -0.55% | 1,927,659 | 7.50M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | 0.73% | 2,476,185 | 1.34M |
| 55 | ORKA | Oruka Therapeutics, Inc. | 4.36B | 2.06% | 2,986,755 | - |
| 56 | CELC | Celcuity Inc. | 4.28B | -0.33% | 2,126,823 | - |
| 57 | ERAS | Erasca, Inc. | 4.25B | -2.22% | 9,641,907 | - |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.05B | -13.38% | 12,095,814 | 56.99M |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 3.96B | 5.72% | 2,007,221 | - |
| 60 | MANE | Veradermics, Incorporated | 3.92B | 2.18% | 826,640 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.06% | 3,354,204 | 596.96M |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.78B | 0.34% | 2,013,872 | 18.07M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | 0.09% | 3,225,526 | 1.10B |
| 64 | DNLI | Denali Therapeutics Inc. | 3.70B | -0.77% | 2,517,615 | - |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.53B | 0.30% | 3,395,662 | - |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.49B | -1.06% | 1,249,646 | 22.57M |
| 67 | RLAY | Relay Therapeutics, Inc. | 3.46B | 2.06% | 10,738,974 | 10.68M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.46B | 1.51% | 90,462 | 803.79M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.40B | 5.11% | 3,509,471 | 164.01M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.29B | -0.69% | 684,962 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -0.04% | 5,480,636 | 415.62M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.27B | 3.13% | 5,111,871 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 3.16B | -1.09% | 1,151,890 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.06B | 0.79% | 2,308,996 | 236.00M |
| 75 | ALMS | Alumis Inc. | 2.98B | 1.56% | 1,882,428 | 8.40M |
| 76 | QURE | uniQure N.V. | 2.92B | -3.88% | 4,859,906 | 18.09M |
| 77 | ELVN | Enliven Therapeutics, Inc. | 2.75B | 0.53% | 2,449,791 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.74B | -0.10% | 2,018,517 | 225.27M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.72B | 0.98% | 402,143 | 535.08M |
| 80 | IRON | Disc Medicine, Inc. | 2.70B | 0.83% | 1,562,334 | - |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.69B | 1.97% | 3,562,375 | 670.00M |
| 82 | DFTX | Definium Therapeutics, Inc. | 2.67B | 0.20% | 2,629,882 | - |
| 83 | KLRA | Kailera Therapeutics, Inc. | 2.58B | 4.03% | 4,355,830 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.55B | -1.52% | 2,353,672 | 865.00K |
| 85 | VERA | Vera Therapeutics, Inc. | 2.52B | 0.23% | 1,497,436 | - |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.44B | 5.13% | 2,960,142 | - |
| 87 | PHVS | Pharvaris N.V. | 2.29B | -1.83% | 182,167 | - |
| 88 | KOD | Kodiak Sciences Inc. | 2.26B | 1.20% | 1,205,926 | - |
| 89 | NTLA | Intellia Therapeutics, Inc. | 2.19B | 3.09% | 8,849,172 | 66.09M |
| 90 | IMNM | Immunome, Inc. | 2.12B | 1.13% | 3,318,515 | 4.02M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 1.98% | 1,172,274 | 298.30M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.06B | -2.18% | 6,114,191 | 52.04M |
| 93 | NKTR | Nektar Therapeutics | 2.06B | 0.10% | 908,332 | 55.63M |
| 94 | MBX | MBX Biosciences, Inc. | 2.05B | 3.46% | 831,963 | - |
| 95 | VCEL | Vericel Corporation | 2.05B | 2.48% | 1,686,062 | 292.09M |
| 96 | BHVN | Biohaven Ltd. | 2.04B | -0.37% | 6,458,979 | - |
| 97 | ZLAB | Zai Lab Limited | 2.04B | 1.68% | 978,119 | 453.28M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 2.03B | -1.99% | 4,062,111 | - |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 3.26% | 2,241,485 | 66.05M |
| 100 | KARD | Kardigan, Inc. | 1.97B | 37.50% | 5,844,442 | - |
| 101 | MESO | Mesoblast Limited | 1.94B | 2.86% | 126,021 | 65.38M |
| 102 | NUVB | Nuvation Bio Inc. | 1.94B | 4.32% | 4,730,292 | 143.05M |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.93B | 2.45% | 1,971,060 | 32.08M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | -1.45% | 770,604 | 899.11M |
| 105 | ADMA | ADMA Biologics, Inc. | 1.93B | -1.31% | 8,921,856 | 509.86M |
| 106 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -0.18% | 159,487 | 1.20B |
| 107 | GENB | Generate Biomedicines, Inc. | 1.86B | 4.47% | 2,604,767 | 30.30M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 3.36% | 5,610,425 | 2.18B |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | 3.72% | 6,368,906 | 7.47M |
| 110 | VRDN | Viridian Therapeutics, Inc. | 1.84B | -0.48% | 4,030,300 | 70.92M |
| 111 | NRIX | Nurix Therapeutics, Inc. | 1.81B | 2.51% | 4,244,617 | 71.78M |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.79B | 1.27% | 355,435 | 20.00M |
| 113 | NBTX | Nanobiotix S.A. | 1.77B | 0.06% | 49,583 | 38.27M |
| 114 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | -0.51% | 23,714,726 | 285.61M |
| 115 | PGEN | Precigen, Inc. | 1.72B | 1.90% | 4,755,703 | 31.60M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 3.86% | 24,853,721 | 66.41M |
| 117 | ZYME | Zymeworks Inc. | 1.69B | - | 699,017 | 81.26M |
| 118 | ABCL | AbCellera Biologics Inc. | 1.69B | 1.65% | 6,803,880 | 79.21M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.68B | -2.58% | 2,531,395 | - |
| 120 | SION | Sionna Therapeutics, Inc. | 1.68B | 1.55% | 736,761 | - |
| 121 | SNDX | Syndax Pharmaceuticals, Inc. | 1.68B | -0.21% | 3,994,802 | 217.17M |
| 122 | ANAB | AnaptysBio, Inc. | 1.67B | 1.30% | 827,833 | 232.39M |
| 123 | INVA | Innoviva, Inc. | 1.66B | -0.66% | 1,403,827 | 420.69M |
| 124 | CAPR | Capricor Therapeutics, Inc. | 1.64B | 1.54% | 3,095,328 | 11.13M |
| 125 | URGN | UroGen Pharma Ltd. | 1.64B | 2.32% | 847,099 | 140.49M |
| 126 | SEPN | Septerna, Inc. | 1.63B | 1.03% | 283,355 | 72.26M |
| 127 | PVLA | Palvella Therapeutics, Inc. | 1.62B | 0.42% | 383,247 | - |
| 128 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | -0.54% | 2,507,724 | 42.95M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.54B | -1.51% | 8,795,300 | 65.50M |
| 130 | AAPG | Ascentage Pharma Group International | 1.54B | 0.18% | 12,797 | 82.08M |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.53B | 1.35% | 1,934,590 | - |
| 132 | GHRS | GH Research PLC | 1.53B | 2.49% | 544,558 | - |
| 133 | NVAX | Novavax, Inc. | 1.50B | -3.89% | 9,458,287 | 596.34M |
| 134 | SLS | SELLAS Life Sciences Group, Inc. | 1.50B | 3.74% | 14,747,756 | - |
| 135 | ATAI | AtaiBeckley Inc. | 1.49B | -0.25% | 6,624,978 | 3.49M |
| 136 | ARDX | Ardelyx, Inc. | 1.49B | 3.60% | 9,839,084 | 427.68M |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.48B | 1.21% | 859,253 | - |
| 138 | IMCR | Immunocore Holdings plc | 1.45B | 0.18% | 812,333 | 412.81M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.45B | -0.07% | 3,008,109 | 2.71B |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.42B | 3.38% | 1,390,454 | 20.00M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.41B | 0.10% | 774,519 | - |
| 142 | SVRA | Savara Inc. | 1.39B | 2.23% | 4,761,530 | - |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -1.22% | 473,543 | 1.30M |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.34B | -0.38% | 8,405,954 | 204.73M |
| 145 | IMTX | Immatics N.V. | 1.34B | 2.73% | 438,413 | 43.00M |
| 146 | AKTS | Aktis Oncology, Inc. | 1.33B | 2.38% | 552,078 | 8.28M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.31B | 7.30% | 1,515,227 | - |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.31B | -1.34% | 1,466,884 | - |
| 149 | DMRA | Damora Therapeutics, Inc. | 1.31B | -0.89% | 1,746,731 | - |
| 150 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | 10.55% | 1,547,437 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 6.46% | 2,128,154 | 10.00M |
| 152 | MNKD | MannKind Corporation | 1.22B | 0.51% | 16,622,952 | 360.78M |
| 153 | WVE | Wave Life Sciences Ltd. | 1.19B | 3.53% | 5,099,054 | 71.80M |
| 154 | ABSI | Absci Corporation | 1.16B | 3.20% | 8,444,165 | 1.84M |
| 155 | EYPT | EyePoint, Inc. | 1.14B | 3.27% | 1,290,157 | 7.61M |
| 156 | MGTX | MeiraGTx Holdings plc | 1.05B | 8.74% | 2,519,936 | 79.76M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | -0.75% | 1,977,168 | - |
| 158 | JBIO | Jade Biosciences, Inc. | 998.43M | -0.30% | 4,785,524 | - |
| 159 | SPTX | Seaport Therapeutics, Inc. | 972.65M | 6.26% | 1,326,793 | - |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 958.28M | -2.53% | 2,277,913 | 98.99M |
| 161 | DBVT | DBV Technologies S.A. | 957.74M | -4.61% | 320,272 | 5.74M |
| 162 | SANA | Sana Biotechnology, Inc. | 944.68M | 3.62% | 6,743,940 | - |
| 163 | XNCR | Xencor, Inc. | 937.15M | -1.10% | 1,813,109 | 97.36M |
| 164 | SLBT | SL Science Holding Limited | 935.81M | -9.25% | 488,769 | - |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 923.71M | 4.09% | 3,115,452 | - |
| 166 | PHAR | Pharming Group N.V. | 913.52M | 1.77% | 3,254 | 369.49M |
| 167 | ODTX | Odyssey Therapeutics, Inc. | 899.61M | 3.19% | 1,602,712 | 2.98M |
| 168 | ABUS | Arbutus Biopharma Corporation | 898.80M | 2.71% | 4,935,579 | 191.45M |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 892.83M | -1.47% | 3,925,687 | 69.64M |
| 170 | DRTS | Alpha Tau Medical Ltd. | 881.92M | 1.77% | 574,439 | - |
| 171 | KURA | Kura Oncology, Inc. | 881.53M | 3.76% | 1,698,862 | 71.64M |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 878.86M | -1.62% | 2,771,345 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 867.20M | 0.49% | 1,251,085 | 13.73M |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 864.20M | -1.09% | 1,121,963 | 204.89M |
| 175 | LBRX | LB Pharmaceuticals Inc | 860.30M | -0.17% | 513,122 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 854.75M | -0.78% | 952,850 | 109.78M |
| 177 | REPL | Replimune Group, Inc. | 841.41M | 1.90% | 2,571,701 | - |
| 178 | OLMA | Olema Pharmaceuticals, Inc. | 830.67M | 0.74% | 2,868,788 | - |
| 179 | SLDB | Solid Biosciences Inc. | 820.09M | 13.95% | 14,768,079 | - |
| 180 | GERN | Geron Corporation | 808.32M | 2.44% | 22,995,891 | 196.12M |
| 181 | ANNX | Annexon, Inc. | 802.83M | -0.81% | 7,342,604 | - |
| 182 | ANRO | Alto Neuroscience, Inc. | 798.04M | 4.36% | 558,218 | - |
| 183 | VOR | Vor Biopharma Inc. | 785.15M | -3.53% | 2,874,958 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 776.96M | 4.27% | 1,036,639 | - |
| 185 | AVTX | Avalo Therapeutics, Inc. | 772.71M | -4.55% | 6,417,380 | 59.00K |
| 186 | EVMN | Evommune, Inc. | 769.35M | 3.44% | 665,042 | 10.00M |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 762.58M | 2.30% | 1,948,448 | 122.29M |
| 188 | OMER | Omeros Corporation | 744.02M | 6.64% | 2,633,428 | 9.89M |
| 189 | IVA | Inventiva S.A. | 724.70M | 1.13% | 3,549,713 | 7.94M |
| 190 | TENX | Tenax Therapeutics, Inc. | 706.54M | 1.10% | 2,691,054 | - |
| 191 | RLMD | Relmada Therapeutics, Inc. | 705.91M | 1.97% | 4,105,002 | - |
| 192 | AURA | Aura Biosciences, Inc. | 699.30M | 0.48% | 1,263,808 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 690.31M | 2.04% | 23,548,239 | 22.00K |
| 194 | CRMD | CorMedix Inc. | 680.18M | - | 2,520,414 | 400.05M |
| 195 | OCS | Oculis Holding AG | 677.55M | -0.71% | 772,599 | 1.40M |
| 196 | CLYM | Climb Bio, Inc. | 655.63M | 0.97% | 1,246,774 | - |
| 197 | CTMX | CytomX Therapeutics, Inc. | 642.22M | -0.34% | 9,728,896 | 35.54M |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 628.49M | 1.81% | 4,322,755 | 8.37M |
| 199 | SGP | SpyGlass Pharma, Inc. | 625.08M | 2.75% | 144,287 | - |
| 200 | IMMX | Immix Biopharma, Inc. | 620.78M | -4.49% | 7,434,821 | - |
| 201 | RIGL | Rigel Pharmaceuticals, Inc. | 608.90M | -1.38% | 972,697 | 299.77M |
| 202 | CADL | Candel Therapeutics, Inc. | 608.88M | 4.01% | 8,197,152 | - |
| 203 | DRUG | Bright Minds Biosciences Inc. | 608.01M | 1.92% | 239,378 | - |
| 204 | TRAX | First Tracks Biotherapeutics, Inc. | 607.83M | -4.13% | 1,915,185 | - |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 605.61M | -1.56% | 2,293,216 | - |
| 206 | DNA | Ginkgo Bioworks Holdings, Inc. | 599.03M | 7.25% | 1,545,900 | 151.40M |
| 207 | CBIO | Crescent Biopharma, Inc. | 587.82M | -2.86% | 119,469 | 11.88M |
| 208 | PRME | Prime Medicine, Inc. | 583.39M | 2.22% | 3,501,632 | 4.03M |
| 209 | GYRE | Gyre Therapeutics, Inc. | 571.07M | 2.80% | 85,722 | 117.05M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 566.45M | -0.10% | 106,749 | - |
| 211 | PROK | ProKidney Corp. | 552.77M | 4.57% | 578,592 | 889.00K |
| 212 | MDXG | MiMedx Group, Inc. | 546.63M | 1.66% | 2,127,068 | 389.42M |
| 213 | AGMB | AgomAb Therapeutics NV | 540.74M | 8.71% | 188,958 | - |
| 214 | XOMA | XOMA Royalty Corporation | 525.34M | 0.41% | 88,326 | 48.56M |
| 215 | ALT | Altimmune, Inc. | 525.08M | 2.27% | 11,688,234 | 36.00K |
| 216 | RZLT | Rezolute, Inc. | 524.42M | 4.80% | 2,812,693 | - |
| 217 | EIKN | Eikon Therapeutics, Inc. | 520.27M | -1.23% | 320,266 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 504.99M | 2.55% | 892,222 | 88.24M |
| 219 | NGNE | Neurogene Inc. | 498.23M | 2.40% | 308,925 | 925.00K |
| 220 | VALN | Valneva SE | 498.22M | 0.56% | 13,047 | 180.25M |
| 221 | ACHV | Achieve Life Sciences, Inc. | 497.90M | -9.51% | 6,945,503 | - |
| 222 | ARVN | Arvinas, Inc. | 494.88M | - | 957,543 | 89.40M |
| 223 | STRO | Sutro Biopharma, Inc. | 490.98M | 4.29% | 287,924 | 99.61M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 488.48M | 0.37% | 1,474,117 | - |
| 225 | ASMB | Assembly Biosciences, Inc. | 484.33M | 1.20% | 298,862 | 71.10M |
| 226 | ARTV | Artiva Biotherapeutics, Inc. | 477.14M | -1.21% | 1,747,007 | 251.00K |
| 227 | PRTA | Prothena Corporation plc | 467.51M | 5.18% | 1,390,829 | 57.94M |
| 228 | CABA | Cabaletta Bio, Inc. | 463.08M | - | 17,204,399 | - |
| 229 | CCCC | C4 Therapeutics, Inc. | 458.85M | 5.87% | 3,426,865 | 34.86M |
| 230 | MNPR | Monopar Therapeutics Inc. | 451.97M | 4.78% | 128,097 | - |
| 231 | CTNM | Contineum Therapeutics, Inc. | 446.39M | -1.81% | 313,461 | - |
| 232 | INDP | Indaptus Therapeutics, Inc. | 441.65M | -13.33% | 301,057 | - |
| 233 | FBRX | Forte Biosciences, Inc. | 436.18M | 1.31% | 228,693 | - |
| 234 | VTVT | vTv Therapeutics Inc. | 434.83M | 3.30% | 56,212 | 36.84M |
| 235 | PRLD | Prelude Therapeutics Incorporated | 428.45M | -0.69% | 1,076,619 | 16.72M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.84M | 3.02% | 471,611 | - |
| 237 | OVID | Ovid Therapeutics Inc. | 423.67M | -6.20% | 15,348,112 | 7.12M |
| 238 | OCGN | Ocugen, Inc. | 419.77M | 0.81% | 26,259,507 | 4.47M |
| 239 | BNTC | Benitec Biopharma Inc. | 417.41M | 2.97% | 154,627 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 413.01M | 1.78% | 579,417 | 109.16M |
| 241 | EDIT | Editas Medicine, Inc. | 412.81M | 5.49% | 3,286,390 | 38.69M |
| 242 | SGMT | Sagimet Biosciences Inc. | 412.50M | 2.30% | 3,592,527 | - |
| 243 | ANL | Adlai Nortye Ltd. | 404.00M | -1.56% | 42,913 | 5.00M |
| 244 | RGNX | REGENXBIO Inc. | 403.24M | -1.27% | 3,205,429 | 87.82M |
| 245 | AUTL | Autolus Therapeutics plc | 401.88M | -1.31% | 844,819 | 92.62M |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 398.03M | 4.20% | 866,269 | 9.01M |
| 247 | LXEO | Lexeo Therapeutics, Inc. | 387.11M | -1.00% | 1,481,272 | - |
| 248 | PBYI | Puma Biotechnology, Inc. | 384.80M | 4.56% | 427,438 | 227.18M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 379.95M | 2.82% | 3,563,579 | - |
| 250 | STTK | Shattuck Labs, Inc. | 379.57M | 4.43% | 1,221,912 | 1.00M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 368.13M | -0.04% | 253,871 | 69.21M |
| 252 | NVCT | Nuvectis Pharma, Inc. | 366.58M | 9.77% | 323,536 | - |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 365.80M | 6.01% | 11,287,223 | - |
| 254 | CMPX | Compass Therapeutics, Inc. | 363.78M | -1.46% | 9,276,284 | 850.00K |
| 255 | VSTM | Verastem, Inc. | 362.04M | -1.20% | 4,765,945 | 49.59M |
| 256 | ZURA | Zura Bio Limited | 356.24M | 3.59% | 1,765,869 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 348.92M | 0.69% | 607,583 | - |
| 258 | VNDA | Vanda Pharmaceuticals Inc. | 348.79M | -2.60% | 1,728,920 | 217.78M |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 343.18M | -2.54% | 92,522 | - |
| 260 | UPB | Upstream Bio, Inc. | 340.12M | 1.63% | 829,656 | 3.32M |
| 261 | OABI | OmniAb, Inc. | 339.24M | 15.27% | 1,046,534 | 28.94M |
| 262 | CNXU | Conexeu Sciences Inc. | 335.59M | 2.00% | 36,150 | - |
| 263 | IRD | Opus Genetics, Inc. | 331.28M | 0.25% | 1,056,530 | 11.98M |
| 264 | ABEO | Abeona Therapeutics Inc. | 328.86M | 2.12% | 1,111,173 | 14.54M |
| 265 | SLN | Silence Therapeutics plc | 327.33M | 2.51% | 382,922 | 839.00K |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 315.22M | 2.09% | 226,717 | - |
| 267 | FENC | Fennec Pharmaceuticals Inc. | 314.72M | 0.89% | 372,699 | 51.00M |
| 268 | PALI | Palisade Bio, Inc. | 313.08M | 6.25% | 4,040,334 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 311.87M | 8.93% | 1,484,403 | 1.00 |
| 270 | ELDN | Eledon Pharmaceuticals, Inc. | 303.03M | 5.95% | 2,640,201 | - |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 301.65M | -3.20% | 1,697,954 | 14.78M |
| 272 | LYEL | Lyell Immunopharma, Inc. | 297.28M | 1.76% | 359,949 | 31.00K |
| 273 | NAUT | Nautilus Biotechnology, Inc. | 289.74M | 4.59% | 475,524 | - |
| 274 | IVVD | Invivyd, Inc. | 285.74M | 4.16% | 21,078,600 | 55.87M |
| 275 | IMRX | Immuneering Corporation | 285.32M | - | 1,010,446 | - |
| 276 | RNAC | Cartesian Therapeutics, Inc. | 282.94M | -2.53% | 354,791 | 1.78M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 281.10M | 3.63% | 2,908,294 | 114.70K |
| 278 | NMRA | Neumora Therapeutics, Inc. | 279.78M | -1.31% | 2,200,626 | - |
| 279 | NAGE | Niagen Bioscience, Inc. | 279.34M | 3.86% | 951,141 | 130.42M |
| 280 | BCYC | Bicycle Therapeutics plc | 279.24M | -0.99% | 317,924 | 63.50M |
| 281 | SRZN | Surrozen, Inc. | 269.94M | -3.29% | 246,452 | 7.49M |
| 282 | IFRX | InflaRx N.V. | 266.60M | -0.55% | 1,494,140 | 33.82K |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 263.39M | 2.21% | 575,379 | 26.87M |
| 284 | MGNX | MacroGenics, Inc. | 262.52M | 4.29% | 972,890 | 157.08M |
| 285 | ADAG | Adagene Inc. | 260.33M | 11.61% | 169,927 | 7.67M |
| 286 | ARMP | Armata Pharmaceuticals, Inc. | 259.80M | 0.28% | 21,260 | 5.20M |
| 287 | TRDA | Entrada Therapeutics, Inc. | 255.48M | 4.19% | 339,739 | 5.74M |
| 288 | AVXL | Anavex Life Sciences Corp. | 252.99M | 2.25% | 8,914,887 | - |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 246.54M | 5.71% | 6,100,837 | 80.00M |
| 290 | FHTX | Foghorn Therapeutics Inc. | 243.66M | 2.47% | 191,072 | 28.22M |
| 291 | FATE | Fate Therapeutics, Inc. | 243.61M | 6.63% | 4,122,848 | 6.32M |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 243.41M | 5.83% | 17,523 | 18.47M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 238.92M | 3.10% | 315,194 | 32.72M |
| 294 | ACIU | AC Immune SA | 238.08M | 2.56% | 213,282 | 4.62M |
| 295 | WHWK | Whitehawk Therapeutics, Inc. | 237.72M | 4.74% | 585,155 | 7.15M |
| 296 | CNTN | Canton Strategic Holdings, Inc. | 233.85M | -5.37% | 2,766,946 | - |
| 297 | HELP | Cybin Inc. | 233.67M | 1.97% | 455,826 | - |
| 298 | NGEN | NervGen Pharma Corp. | 233.65M | 0.46% | 1,487,007 | - |
| 299 | CDXS | Codexis, Inc. | 233.60M | 3.63% | 1,748,232 | 78.09M |
| 300 | CHRS | Coherus Oncology, Inc. | 228.29M | 6.47% | 1,288,146 | 46.88M |
| 301 | VYGR | Voyager Therapeutics, Inc. | 224.77M | 2.76% | 664,919 | 36.49M |
| 302 | CLLS | Cellectis S.A. | 224.65M | -3.25% | 160,270 | 75.11M |
| 303 | TARA | Protara Therapeutics, Inc. | 223.69M | -2.21% | 803,681 | - |
| 304 | RNA | Atrium Therapeutics, Inc. | 216.56M | 1.44% | 294,100 | 36.68M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 214.45M | -0.24% | 161,145 | 3.93M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 214.03M | 2.31% | 466,258 | 54.71M |
| 307 | KROS | Keros Therapeutics, Inc. | 210.78M | 2.31% | 400,525 | 33.18M |
| 308 | NERV | Minerva Neurosciences, Inc. | 208.25M | 6.68% | 574,946 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 205.88M | 5.52% | 5,048,971 | - |
| 310 | HUMA | Humacyte, Inc. | 205.23M | -4.59% | 11,323,184 | 2.02M |
| 311 | NKTX | Nkarta, Inc. | 204.62M | 8.33% | 569,249 | - |
| 312 | KPTI | Karyopharm Therapeutics Inc. | 204.42M | -4.04% | 492,124 | 151.12M |
| 313 | QTTB | Q32 Bio Inc. | 201.78M | -7.82% | 407,782 | 53.74M |
| 314 | PRQR | ProQR Therapeutics N.V. | 199.14M | 13.17% | 1,378,018 | 15.73M |
| 315 | ALEC | Alector, Inc. | 194.29M | 12.18% | 1,108,380 | 18.42M |
| 316 | IMUX | Immunic, Inc. | 193.43M | - | 263,701 | - |
| 317 | EQ | Equillium, Inc. | 192.84M | 2.01% | 424,143 | 4.39M |
| 318 | LENZ | LENZ Therapeutics, Inc. | 192.83M | -3.00% | 1,125,381 | 20.99M |
| 319 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.45M | -1.56% | 567,365 | 17.56M |
| 320 | OTLK | Outlook Therapeutics, Inc. | 190.96M | -4.24% | 20,623,163 | 333.14K |
| 321 | CGEN | Compugen Ltd. | 190.12M | 1.01% | 503,829 | 72.66M |
| 322 | KRRO | Korro Bio, Inc. | 187.35M | 17.56% | 736,220 | 3.84M |
| 323 | GALT | Galectin Therapeutics Inc. | 186.05M | 1.99% | 336,735 | - |
| 324 | MDWD | MediWound Ltd. | 183.02M | 0.28% | 69,383 | 14.48M |
| 325 | UNCY | Unicycive Therapeutics, Inc. | 182.90M | -2.84% | 1,478,183 | - |
| 326 | OKUR | OnKure Therapeutics, Inc. | 180.97M | 4.43% | 1,651,265 | - |
| 327 | ANTX | AN2 Therapeutics, Inc. | 179.98M | 2.04% | 480,861 | - |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 178.87M | 9.90% | 1,832,869 | 76.38M |
| 329 | MIST | Milestone Pharmaceuticals Inc. | 176.87M | -0.76% | 1,336,704 | 1.78M |
| 330 | DTIL | Precision BioSciences, Inc. | 175.71M | 4.31% | 420,363 | 45.07M |
| 331 | TTRX | Turn Therapeutics Inc. | 174.86M | -2.65% | 36,642 | - |
| 332 | NBP | NovaBridge Biosciences | 173.47M | -4.46% | 648,098 | - |
| 333 | IPHA | Innate Pharma S.A. | 172.09M | 1.69% | 1,391 | 10.57M |
| 334 | YDES | YD Bio Limited | 170.17M | -3.97% | 15,656 | 510.36K |
| 335 | HURA | TuHURA Biosciences, Inc. | 163.66M | 15.77% | 1,096,271 | - |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 163.23M | 0.44% | 696,825 | - |
| 337 | CRBU | Caribou Biosciences, Inc. | 162.66M | - | 2,539,655 | 11.20M |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 158.79M | 2.37% | 149,655 | 2.00M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 158.54M | 2.68% | 2,551,532 | 225.00K |
| 340 | KZIA | Kazia Therapeutics Limited | 158.38M | -2.74% | 195,952 | 1.27M |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 153.04M | 2.61% | 297,748 | - |
| 342 | ACOG | Alpha Cognition Inc. | 150.46M | 3.44% | 25,621 | 10.83M |
| 343 | TLSA | Tiziana Life Sciences Ltd | 150.00M | 7.41% | 290,851 | - |
| 344 | ENLV | Enlivex Ltd. | 149.86M | 0.60% | 323,676 | - |
| 345 | MOLN | Molecular Partners AG | 145.71M | 2.05% | 1,041 | 856.30K |
| 346 | SPRB | Spruce Biosciences, Inc. | 144.11M | 7.38% | 171,012 | 697.00K |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 143.70M | -0.25% | 777,694 | 2.29M |
| 348 | ADCT | ADC Therapeutics SA | 138.64M | -1.80% | 1,725,034 | 79.18M |
| 349 | GUTS | Fractyl Health, Inc. | 136.17M | 0.98% | 1,410,507 | 3.00K |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 133.42M | 9.56% | 373,752 | 39.99K |
| 351 | SPRO | Spero Therapeutics, Inc. | 132.02M | 8.06% | 7,195,319 | 61.19M |
| 352 | GNLX | Genelux Corporation | 131.67M | 4.04% | 98,793 | 8.00K |
| 353 | CGTX | Cognition Therapeutics, Inc. | 129.56M | 2.11% | 1,303,647 | - |
| 354 | PYXS | Pyxis Oncology, Inc. | 128.61M | 6.84% | 668,652 | 13.86M |
| 355 | CNTB | Connect Biopharma Holdings Limited | 125.93M | -3.85% | 204,158 | 233.00K |
| 356 | AGEN | Agenus Inc. | 124.93M | 1.35% | 868,333 | 123.87M |
| 357 | PEPG | PepGen Inc. | 123.81M | 5.29% | 692,172 | - |
| 358 | ALPS | Alps Group Inc | 119.81M | 3.15% | 20,517 | 3.74M |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 118.23M | 7.10% | 2,184,996 | - |
| 360 | MENS | Jyong Biotech Ltd. | 115.80M | -2.50% | 120,949 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 115.41M | -2.19% | 215,713 | 7.94M |
| 362 | ENGN | enGene Therapeutics Inc. | 115.22M | -1.15% | 885,178 | - |
| 363 | ONCY | Oncolytics Biotech Inc. | 114.58M | 3.03% | 1,129,424 | - |
| 364 | VRXA | VERAXA Biotech AG | 112.97M | -23.55% | 770,371 | - |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 112.30M | 3.74% | 235,547 | - |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 109.84M | 0.43% | 105,766 | - |
| 367 | CBUS | Cibus, Inc. | 103.81M | 5.43% | 808,199 | 3.64M |
| 368 | PTHS | Pelthos Therapeutics Inc. | 100.79M | 7.37% | 46,218 | 27.70M |
| 369 | FBIO | Fortress Biotech, Inc. | 99.33M | -2.61% | 372,231 | 66.16M |
| 370 | VANI | Vivani Medical, Inc. | 99.17M | - | 201,836 | - |
| 371 | ANIX | Anixa Biosciences, Inc. | 99.01M | 8.18% | 600,740 | - |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 96.72M | -3.43% | 26,784 | 37.16M |
| 373 | SEER | Seer, Inc. | 95.67M | 1.16% | 102,095 | 15.17M |
| 374 | BDTX | Black Diamond Therapeutics, Inc. | 95.12M | -0.60% | 1,909,168 | 70.00M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 94.52M | 1.54% | 5,926 | - |
| 376 | CUE | Cue Biopharma, Inc. | 92.65M | 6.47% | 292,229 | 32.73M |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 91.36M | 0.45% | 2,757,454 | 65.34K |
| 378 | PYPD | PolyPid Ltd. | 90.89M | 3.95% | 101,235 | - |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 90.73M | 4.14% | 144,866 | 23.14M |
| 380 | ATHE | Alterity Therapeutics Limited | 89.40M | -5.06% | 19,284 | 4.43M |
| 381 | NRXS | NeurAxis, Inc. | 88.55M | 6.56% | 164,452 | 4.28M |
| 382 | LIXT | Lixte Biotechnology Holdings, Inc. | 88.41M | 9.34% | 1,007,714 | - |
| 383 | CSBR | Champions Oncology, Inc. | 87.76M | -5.57% | 3,906 | 57.95M |
| 384 | OSTX | OS Therapies Incorporated | 85.96M | 12.21% | 1,145,109 | - |
| 385 | ICCC | ImmuCell Corporation | 85.85M | 1.06% | 34,226 | 29.93M |
| 386 | AARD | Aardvark Therapeutics, Inc. | 85.74M | 2.88% | 152,743 | - |
| 387 | BMEA | Biomea Fusion, Inc. | 85.31M | -1.67% | 744,055 | - |
| 388 | RNTX | Rein Therapeutics Inc. | 85.20M | 5.87% | 2,056,659 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 85.12M | 6.06% | 1,381,153 | - |
| 390 | ACET | Adicet Bio, Inc. | 85.06M | - | 36,379 | - |
| 391 | RLYB | Rallybio Corporation | 84.48M | 0.31% | 26,797 | 858.00K |
| 392 | OKYO | OKYO Pharma Limited | 83.44M | 1.91% | 60,235 | - |
| 393 | CRDF | Cardiff Oncology, Inc. | 82.73M | 2.54% | 960,532 | 525.00K |
| 394 | GOSS | Gossamer Bio, Inc. | 82.13M | -6.15% | 23,415,698 | 55.54M |
| 395 | GANX | Gain Therapeutics, Inc. | 80.19M | 5.62% | 503,933 | - |
| 396 | HRTX | Heron Therapeutics, Inc. | 79.02M | 7.80% | 5,463,114 | 150.71M |
| 397 | RANI | Rani Therapeutics Holdings, Inc. | 78.09M | 2.25% | 308,786 | 3.17M |
| 398 | LONA | LeonaBio, Inc. | 76.84M | -2.22% | 8,646 | - |
| 399 | HYFT | MindWalk Holdings Corp. | 75.99M | 2.00% | 269,506 | 20.70M |
| 400 | ANVS | Annovis Bio, Inc. | 74.45M | 0.57% | 1,091,219 | - |
| 401 | PLRX | Pliant Therapeutics, Inc. | 71.83M | -1.69% | 472,903 | - |
| 402 | ELTX | Elicio Therapeutics, Inc. | 70.82M | -18.26% | 5,435,696 | - |
| 403 | XBIT | XBiotech Inc. | 70.43M | -2.53% | 40,396 | - |
| 404 | IMA | ImageneBio, Inc. | 67.67M | 5.45% | 34,301 | 800.00K |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 67.20M | 3.29% | 713,718 | - |
| 406 | KALA | KALA BIO, Inc. | 67.11M | 26.89% | 958,904 | - |
| 407 | BYSI | BeyondSpring Inc. | 66.61M | 1.89% | 35,146 | 1.88M |
| 408 | EXOZ | eXoZymes, Inc. | 66.39M | 23.70% | 19,994 | -700.00 |
| 409 | CING | Cingulate Inc. | 66.25M | -2.54% | 506,498 | - |
| 410 | EDSA | Edesa Biotech, Inc. | 65.31M | 6.83% | 257,454 | - |
| 411 | MNOV | MediciNova, Inc. | 64.97M | -1.49% | 29,462 | 596.64K |
| 412 | MCRB | Seres Therapeutics, Inc. | 64.01M | 2.32% | 124,619 | 1.15M |
| 413 | IBIO | iBio, Inc. | 61.08M | 5.62% | 912,079 | 300.00K |
| 414 | INKT | MiNK Therapeutics, Inc. | 60.48M | -0.57% | 16,523 | - |
| 415 | PMVP | PMV Pharmaceuticals, Inc. | 60.26M | 2.73% | 242,604 | - |
| 416 | TCRX | TScan Therapeutics, Inc. | 60.12M | 2.23% | 447,769 | 9.14M |
| 417 | ENTX | Entera Bio Ltd. | 59.56M | 0.83% | 50,907 | 42.00K |
| 418 | FLNA | Filana Therapeutics, Inc. | 58.94M | 0.83% | 465,033 | - |
| 419 | CNTX | Context Therapeutics Inc. | 58.06M | 5.32% | 3,143,716 | - |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 56.43M | -0.14% | 38,570 | - |
| 421 | IMMP | Immutep Limited | 54.88M | 0.08% | 239,740 | 5.28M |
| 422 | IBO | Impact BioMedical Inc. | 54.15M | -12.96% | 105,866 | 39.00K |
| 423 | PDSB | PDS Biotechnology Corporation | 53.30M | 5.06% | 457,558 | - |
| 424 | XLO | Xilio Therapeutics, Inc. | 52.59M | -0.74% | 56,523 | 53.48M |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 51.77M | 4.03% | 74,860 | - |
| 426 | TIL | Instil Bio, Inc. | 50.86M | -0.79% | 22,519 | - |
| 427 | RADX | Radiopharm Theranostics Limited | 49.80M | 0.79% | 17,176 | 10.86M |
| 428 | ACTU | Actuate Therapeutics, Inc. | 49.53M | 0.98% | 100,514 | - |
| 429 | MREO | Mereo BioPharma Group plc | 49.39M | -0.19% | 1,440,204 | 500.00K |
| 430 | HYPD | Hyperion DeFi, Inc. | 49.01M | -2.27% | 821,606 | 1.04M |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 48.82M | 13.60% | 1,130,322 | - |
| 432 | LTRN | Lantern Pharma Inc. | 48.36M | -2.57% | 209,028 | - |
| 433 | VERU | Veru Inc. | 47.35M | -1.34% | 573,734 | 16.89M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 45.18M | 1.69% | 190,251 | 22.33M |
| 435 | ATYR | aTyr Pharma, Inc. | 44.17M | -2.68% | 1,533,392 | 190.00K |
| 436 | TVGN | Tevogen Bio Holdings Inc. | 41.83M | 2.99% | 7,476 | - |
| 437 | RNXT | RenovoRx, Inc. | 41.49M | 3.29% | 330,606 | 1.49M |
| 438 | ESLA | Estrella Immunopharma, Inc. | 40.88M | -3.96% | 51,505 | - |
| 439 | GNTA | Genenta Science S.p.A. | 39.63M | -8.70% | 138,837 | - |
| 440 | CRVO | CervoMed Inc. | 39.26M | 11.29% | 108,060,054 | 2.09M |
| 441 | INMB | INmune Bio Inc. | 38.55M | 11.54% | 446,953 | 50.00K |
| 442 | APLM | Apollomics, Inc. | 38.43M | 25.34% | 45,632 | 8.84M |
| 443 | GRCE | Grace Therapeutics, Inc. | 36.83M | 7.21% | 280,273 | - |
| 444 | GRDX | GridAI Technologies Corp. | 35.93M | 9.09% | 181,391 | - |
| 445 | NTRB | Nutriband Inc. | 35.25M | -5.23% | 29,059 | 1.80M |
| 446 | ABVC | ABVC BioPharma, Inc. | 34.11M | -0.74% | 77,035 | 797.92K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 32.67M | -1.31% | 39,807 | 4.71M |
| 448 | DARE | Daré Bioscience, Inc. | 32.51M | 4.33% | 174,805 | 1.16M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 32.32M | 0.98% | 130,679 | 90.00K |
| 450 | BOLD | Boundless Bio, Inc. | 32.12M | 2.14% | 80,382 | - |
| 451 | LSTA | Lisata Therapeutics, Inc. | 32.05M | -0.28% | 41,517 | 170.00K |
| 452 | NNVC | NanoViricides, Inc. | 31.89M | 4.48% | 262,205 | - |
| 453 | SER | Serina Therapeutics, Inc. | 31.29M | 6.06% | 187,679 | 130.00K |
| 454 | SNTI | Senti Biosciences Holdings, Inc. | 29.02M | -2.01% | 114,855 | 38.00K |
| 455 | PSTV | Plus Therapeutics, Inc. | 28.91M | -2.55% | 214,522 | 5.18M |
| 456 | DYAI | Dyadic International, Inc. | 28.50M | -7.85% | 217,456 | 3.81M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 28.44M | 14.13% | 241,013 | - |
| 458 | LITS | Lite Strategy, Inc. | 28.17M | -9.94% | 602,336 | - |
| 459 | IGC | IGC Pharma, Inc. | 27.16M | -0.29% | 631,197 | 1.11M |
| 460 | KYNB | Kyntra Bio, Inc. | 27.12M | -2.17% | 15,594 | 7.44M |
| 461 | BRNS | Barinthus Biotherapeutics plc | 27.05M | -5.19% | 8,160 | 14.97M |
| 462 | VTGN | Vistagen Therapeutics, Inc. | 26.55M | -2.87% | 1,085,095 | 789.00K |
| 463 | LGVN | Longeveron Inc. | 25.54M | -2.37% | 240,915 | 1.22M |
| 464 | EVAX | Evaxion A/S | 25.44M | -8.13% | 42,455 | 7.53M |
| 465 | BCTX | BriaCell Therapeutics Corp. | 25.30M | 3.57% | 54,553 | - |
| 466 | PLRZ | Polyrizon Ltd. | 25.12M | 1.44% | 66,730 | - |
| 467 | SKYE | Skye Bioscience, Inc. | 24.85M | -0.59% | 157,161 | - |
| 468 | TVRD | Tvardi Therapeutics, Inc. | 24.67M | 1.94% | 103,463 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 24.58M | -4.28% | 166,289 | - |
| 470 | FTH | Faeth Therapeutics, Inc. | 23.91M | 7.03% | 65,695 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 23.29M | - | 150,499 | -13.27K |
| 472 | CLRB | Cellectar Biosciences, Inc. | 22.30M | 12.50% | 278,538 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 22.18M | -1.48% | 46,576 | 3.55M |
| 474 | ALLR | Allarity Therapeutics, Inc. | 22.11M | 6.72% | 297,885 | 345.00K |
| 475 | PLUR | Pluri Inc. | 21.79M | -10.22% | 40,297 | 1.08M |
| 476 | CELU | Celularity Inc. | 21.78M | -5.40% | 47,535 | 26.55M |
| 477 | PTN | Palatin Technologies, Inc. | 21.74M | -4.33% | 12,870 | 12.88M |
| 478 | VYNE | VYNE Therapeutics Inc. | 21.17M | 0.68% | 247,693 | 454.00K |
| 479 | LPCN | Lipocine Inc. | 19.21M | -0.43% | 122,355 | 2.00M |
| 480 | GTBP | GT Biopharma, Inc. | 18.54M | 11.98% | 1,977,633 | - |
| 481 | PASG | Passage Bio, Inc. | 17.93M | 4.88% | 68,230 | - |
| 482 | NCEL | NewcelX Ltd. | 17.82M | 4.13% | 15,299 | - |
| 483 | TPST | Tempest Therapeutics, Inc. | 17.64M | -0.80% | 50,986 | - |
| 484 | AEON | AEON Biopharma, Inc. | 17.57M | -0.83% | 60,374 | - |
| 485 | ATOS | Atossa Therapeutics, Inc. | 17.31M | 1.26% | 193,503 | - |
| 486 | LNAI | Lunai Bioworks Inc. | 17.14M | -5.50% | 1,042,826 | 20.94K |
| 487 | HOWL | Werewolf Therapeutics, Inc. | 17.07M | 2.12% | 1,575,715 | 1.14M |
| 488 | MLEC | Moolec Science SA | 17.02M | 5.41% | 70,288 | 7.83M |
| 489 | CRIS | Curis, Inc. | 16.83M | 3.69% | 898,606 | 7.06M |
| 490 | KTTA | Pasithea Therapeutics Corp. | 16.71M | -0.46% | 196,337 | - |
| 491 | QNCX | Quince Therapeutics, Inc. | 15.41M | 4.66% | 736,595 | - |
| 492 | MBRX | Moleculin Biotech, Inc. | 15.37M | 2.86% | 379,152 | - |
| 493 | HIND | Vyome Holdings, Inc. | 15.23M | -0.46% | 26,363 | 152.72K |
| 494 | CVM | CEL-SCI Corporation | 15.07M | -5.45% | 524,279 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 15.00M | 1.19% | 256,914 | 5.61M |
| 496 | XCUR | Exicure, Inc. | 14.72M | 7.44% | 52,933 | 500.00K |
| 497 | BLRX | BioLineRx Ltd. | 14.27M | 4.64% | 7,860 | 1.40M |
| 498 | INAB | IN8bio, Inc. | 14.08M | -2.72% | 52,942 | - |
| 499 | OSRH | OSR Holdings, Inc. | 13.75M | 1.98% | 816,228 | 2.63M |
| 500 | COCP | Cocrystal Pharma, Inc. | 13.72M | 2.43% | 74,278 | 225.00K |